DK0925064T3 - 5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst - Google Patents

5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst

Info

Publication number: DK0925064T3
Authority: DK; Denmark
Prior art keywords: alpha; beta; androsten; diol; inhibitor
Prior art date: 1996-04-11

Application number

DK97920244T

Other languages

English (en)

Inventor

Roger M Loria

Original Assignee

Roger M Loria

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-04-11

Filing date

1997-04-10

Publication date

2003-10-20

1997-04-10 Application filed by Roger M Loria filed Critical Roger M Loria

2003-10-20 Application granted granted Critical

2003-10-20 Publication of DK0925064T3 publication Critical patent/DK0925064T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

DK97920244T 1996-04-11 1997-04-10 5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst DK0925064T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1504296P	1996-04-11	1996-04-11
US1898596P	1996-06-04	1996-06-04
PCT/US1997/005849 WO1997037662A1 (en)	1996-04-11	1997-04-10	5-ANDROSTENE 3β,17α DIOL AS AN INHIBITOR OF TUMOR GROWTH

Publications (1)

Publication Number	Publication Date
DK0925064T3 true DK0925064T3 (da)	2003-10-20

Family

ID=26686886

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97920244T DK0925064T3 (da)	1996-04-11	1997-04-10	5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst

Country Status (8)

Country	Link
EP (1)	EP0925064B1 (da)
JP (1)	JP2000508643A (da)
AT (2)	ATE243518T1 (da)
DE (2)	DE69723087T2 (da)
DK (1)	DK0925064T3 (da)
ES (2)	ES2254828T3 (da)
PT (1)	PT925064E (da)
WO (1)	WO1997037662A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1362591T3 (da) *	1996-04-11	2006-04-10	Roger M Loria	Anvendelse af en sammensætning indeholdende 5-androsten-3beta, 17alfa-diol
US7005428B1 (en)	1998-06-11	2006-02-28	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en)	1998-06-11	2002-10-15	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
EP1955700B9 (en) *	1999-09-30	2011-09-07	Harbor BioSciences, Inc.	Therapeutic treatment of androgen receptor driven conditions
AU2001241779A1 (en)	2000-02-25	2001-09-03	Hollis-Eden Pharmaceuticals, Inc.	Method of treatment of prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4898694A (en) *	1987-11-25	1990-02-06	Schwartz Arthur G	17-Hydroxy-steroids
US5461042A (en) *	1988-12-30	1995-10-24	Loria; Roger M.	Regulation of the immune system
US5206008A (en) *	1991-04-15	1993-04-27	Virginia Commonwealth University	Enhancement of immune response
US5478566A (en) *	1993-09-29	1995-12-26	Loria; Roger M.	Stimulation of cytokine production

1997
- 1997-04-10 DK DK97920244T patent/DK0925064T3/da active
- 1997-04-10 ES ES03014193T patent/ES2254828T3/es not_active Expired - Lifetime
- 1997-04-10 AT AT97920244T patent/ATE243518T1/de not_active IP Right Cessation
- 1997-04-10 ES ES97920244T patent/ES2202606T3/es not_active Expired - Lifetime
- 1997-04-10 AT AT03014193T patent/ATE311886T1/de not_active IP Right Cessation
- 1997-04-10 JP JP9536454A patent/JP2000508643A/ja not_active Ceased
- 1997-04-10 DE DE69723087T patent/DE69723087T2/de not_active Expired - Fee Related
- 1997-04-10 PT PT97920244T patent/PT925064E/pt unknown
- 1997-04-10 WO PCT/US1997/005849 patent/WO1997037662A1/en active IP Right Grant
- 1997-04-10 DE DE60308917T patent/DE60308917T2/de not_active Expired - Fee Related
- 1997-04-10 EP EP97920244A patent/EP0925064B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0925064A4 (en)	2001-11-07
DE69723087D1 (de)	2003-07-31
EP0925064B1 (en)	2003-06-25
ES2202606T3 (es)	2004-04-01
EP0925064A1 (en)	1999-06-30
ES2254828T3 (es)	2006-06-16
PT925064E (pt)	2003-11-28
DE60308917T2 (de)	2006-12-28
WO1997037662A1 (en)	1997-10-16
ATE243518T1 (de)	2003-07-15
ATE311886T1 (de)	2005-12-15
DE69723087T2 (de)	2004-05-06
JP2000508643A (ja)	2000-07-11
DE60308917D1 (de)	2006-11-16

Similar Documents

Publication	Publication Date	Title
GR3036188T3 (en)	2001-10-31	Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
AU1750097A (en)	1997-08-20	Highly concentrated, lyophilized, and liquid factor ix formulations
AU2332188A (en)	1989-04-20	Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
PT758248E (pt)	2003-11-28	Formulacoes para o factor ix
TR200100366T2 (tr)	2001-11-21	Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
ES2195664T3 (es)	2003-12-01	Uso de fumaratos de dialquilo.
NO971889L (no)	1997-06-23	Forbindelser og sammensetninger for levering av aktive midler
NO20001583D0 (no)	2000-03-27	Stimulering av hematopoetiske celler in vitro
DE3161494D1 (en)	1983-12-29	Cosmetic preparations
AU644610B2 (en)	1993-12-16	Synergistic microbicidal combinations
HK1142093A1 (en)	2010-11-26	Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
IL128205A0 (en)	1999-11-30	Potassium channel inhibitors and pharmaceutical compositions containing the same
MY100641A (en)	1990-12-29	Neutral metalloendopeptidase inhibitors in the treatment of hypertension.
GB2184354B (en)	1990-04-11	Stabilized human tissue plasminogen activator compositions
ZA933598B (en)	1993-12-13	New pharmaceutical used of krill enyzmes
FR2662698B1 (da)	1995-03-24
FR2751879B1 (fr)	1998-10-30	Composition pharmaceutique contre les tumeurs et infections a papillomavirus
AU8332791A (en)	1992-03-02	Oral pharmaceutical compositions containing melatonin
DK0925064T3 (da)	2003-10-20	5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst
AU4751797A (en)	1998-05-11	Defined systems for epithelial cell culture and use thereof
CA2252110A1 (en)	1997-10-16	5-androstene 3.beta.,17.alpha. diol as an inhibitor of tumor growth
MX9602407A (es)	1997-02-28	Composiciones farmaceuticas.
MX9703208A (es)	1997-07-31	Tetra-y pentapeptidos substituidos inhibidores de proteina; farnesil transferasa.
IT1267004B1 (it)	1997-01-24	Proteine estratte dai semi di saponaria ocymoides e di vaccaria pyramidata, loro preparazione ed uso come antitumorale ed antivirale.